Ballonkyphoplastie zur Behandlung osteoporotischer Wirbelfrakturen: Indikationen – Behandlungsstrategie – Komplikationen

Zusammenfassung

Bei der Ballonkyphoplastie handelt es sich um ein inzwischen hoch standardisiertes und weit verbreitetes minimalinvasives Verfahren zur Stabilisierung und Wiederaufrichtung insbesondere schmerzhafter osteoporotischer Wirbelkörperfrakturen. Im Rahmen der flächendeckenden Anwendung mehren sich jedoch auch die Berichte über stattgehabte Komplikationen. Außerdem gelten zahlreiche unterschiedliche Standards bezüglich der Indikation zu diesem Eingriff. Der folgende Artikel soll neben einem Überblick über die Technik des Verfahrens die Indikationen aufzeigen und die möglichen Komplikationen dieses vermeintlichen Routineeingriffs anhand einiger Beispiele aus der täglichen Praxis beleuchten.

Abstract

Background: Considering the demographic changes in the populations of Germany and Europe as a whole, the field of geriatric traumatology is gaining more and more importance within the specialty of orthopedic and trauma surgery. The high prevalence of osteoporosis in this specific group of patients poses a special challenge, with vertebral compression fractures being the by far most common osteoporosis-related fractures. These fractures present with acute as well as chronic back pain leading to severe consequences for the affected patients. Mobility and quality of life are often heavily impaired. Furthermore, higher morbidity and mortality as well as higher risk for further fractures have been proven in these patients. Method: Balloon kyphoplasty has become a more frequently used therapy and is now offered broadly. This treatment addresses stable fractures not involving the posterior margin of the vertebrae. With increasing application of this surgical procedure the number of complication reports is also rising. The following article gives an overview of the technique, indications and the possible complications by giving several examples from the daily practice and reviewing the relevant literature. Results: Cement leakage of the treated vertebrae is the most common complication associated with balloon kyphoplasty. In almost all cases this occurs due to too early application of the cement, not having reached its optimum in viscosity. Literature research shows a percentage rate of about 9 % for cement leakage. Thus, balloon kyphoplasty provides more safety for the patient than vertebroplasty, for which cement leakage rates of up to 41 % are reported. Other studies report cement leakage ratios of 4–10 % for kyphoplasty versus 20–70 % for vertebroplasty. Overall the percentage of cement leakage is clearly increased in osteoporotic fractures compared to non-osteoporotic fractures, with the cement leaking mainly into the spinal disc space. So far, valid data in order to further explore the consequences of intradiscal cements are lacking. Most relevant for everyday practice are cement leakages that have become symptomatic. Depending on the localisation they present with dysaesthesia culminating in radicular pain or even paraplegia. Cement leakage into vessels can, depending on the amount of cement, lead to embolism of pulmonary arteries. Complications due to the surgical technique, postoperative infections, bleeding or cardiovascular complications are rare with less than 1 %. The probability for symptomatic cement leakage averages about 1.3 % for balloon kyphoplasty. Another discussion, for which at present there is no evidence-based verification, is concerned with the higher risk for adjacent vertebral fractures after cement augmentation of an osteoporotic vertebral compression fracture. At present the degree of osteoporosis and more important the number of osteoporosis-related fractures must be the relevant predictor for adjacent fractures of neighbouring vertebrae. Conclusion: Balloon kyphoplasty is a highly standardised and widely used minimally invasive procedure for stabilising and augmenting painful osteoporotic fractures of the vertebral body. When surgery is indicated carefully and is carried out subtly, the risk of complications is reasonable and the outcome is promising. Viscosity of the used cement has to be adequate and it must not be inserted with too high a pressure. A causal connection between cement viscosity and risk of cement leakage has been proven in experimental studies. During application of PMMA cement a thorough fluoroscopic monitoring must take place in order to detect cement leakage at an early stage and if necessary stop application. These procedures should be reserved for clinical centres and surgeons who are able to surgically handle possible complications such as compression of the spinal cord. On the basis of our own experience we also recommend treatment in a hospital with an integrated osteoporosis centre and consecutive treatment in specialised outpatient care. Standards in primary care as well as after treatment can be introduced thereby. Also communication with practitioner concerned with outpatient care is simplified, which leads to enduring therapeutic outcome.

Schlüsselwörter

Ballonkyphoplastie - Wirbelkörperfraktur - Osteoporose - Komplikationen - Zementaustritt

Key words

balloon kyphoplasty - vertebral body fracture - osteoporosis - complications - cement leakage

Literatur

• 1 Aebli N, Krebs J, Davis G et al. Fat embolism and acute hypotension during vertebroplasty: an experimental study in sheep.  Spine (Phila Pa 1976). 2002;  27 460-466
• 2 Belkoff S M, Mathis J M, Jasper L E et al. An ex vivo biomechanical evaluation of a hydroxyapatite cement for use with vertebroplasty.  Spine (Phila Pa 1976). 2001;  26 1542-1546
• 3 Berlemann U, Heini P F. [Percutaneous cementing techniques in treatment of osteoporotic spinal sintering].  Unfallchirurg. 2002;  105 2-8
• 4 Black D M, Arden N K, Palermo L et al. Prevalent vertebral deformities predict hip fractures and new vertebral deformities but not wrist fractures. Study of Osteoporotic Fractures Research Group.  J Bone Miner Res. 1999;  14 821-828
• 5 Black D M, Bilezikian J P, Ensrud K E et al. One year of alendronate after one year of parathyroid hormone (1–84) for osteoporosis.  N Engl J Med. 2005;  353 555-565
• 6 Black D M, Cummings S R, Karpf D B et al. Randomised trial of effect of alendronate on risk of fracture in women with existing vertebral fractures. Fracture Intervention Trial Research Group.  Lancet. 1996;  348 1535-1541
• 7 Black D M, Delmas P D, Eastell R et al. Once-yearly zoledronic acid for treatment of postmenopausal osteoporosis.  N Engl J Med. 2007;  356 1809-1822
• 8 Bohner M, Gasser B, Baroud G et al. Theoretical and experimental model to describe the injection of a polymethylmethacrylate cement into a porous structure.  Biomaterials. 2003;  24 2721-2730
• 9 Buchbinder R, Osborne R H, Ebeling P R et al. A randomized trial of vertebroplasty for painful osteoporotic vertebral fractures.  N Engl J Med. 2009;  361 557-568
• 10 Center J R, Nguyen T V, Schneider D et al. Mortality after all major types of osteoporotic fracture in men and women: an observational study.  Lancet. 1999;  353 878-882
• 11 Choe D H, Marom E M, Ahrar K et al. Pulmonary embolism of polymethyl methacrylate during percutaneous vertebroplasty and kyphoplasty.  AJR Am J Roentgenol. 2004;  183 1097-1102
• 12 Cooper C, Atkinson E J, Jacobsen S J et al. Population-based study of survival after osteoporotic fractures.  Am J Epidemiol. 1993;  137 1001-1005
• 13 Cortet B, Cotten A, Boutry N et al. Percutaneous vertebroplasty in the treatment of osteoporotic vertebral compression fractures: an open prospective study.  J Rheumatol. 1999;  26 2222-2228
• 14 Cotten A, Dewatre F, Cortet B et al. Percutaneous vertebroplasty for osteolytic metastases and myeloma: effects of the percentage of lesion filling and the leakage of methyl methacrylate at clinical follow-up.  Radiology. 1996;  200 525-530
• 15 Davis J W, Grove J S, Wasnich R D et al. Spatial relationships between prevalent and incident spine fractures.  Bone. 1999;  24 261-264
• 16 Ensrud K E, Thompson D E, Cauley J A et al. Prevalent vertebral deformities predict mortality and hospitalization in older women with low bone mass. Fracture Intervention Trial Research Group.  J Am Geriatr Soc. 2000;  48 241-249
• 17 Fribourg D, Tang C, Sra P et al. Incidence of subsequent vertebral fracture after kyphoplasty.  Spine (Phila Pa 1976). 2004;  29 2270-2276 discussion 2277
• 18 Garfin S R, Lin G, Lieberman I. Retrospective analysis of the outcomes of balloon kyphoplasty to treat vertebral body compression fracture refractory to medical management.  Eur Spine J. 2001;  10 7-8
• 19 Garfin S R, Yuan H A, Reiley M A. New technologies in spine: kyphoplasty and vertebroplasty for the treatment of painful osteoporotic compression fractures.  Spine (Phila Pa 1976). 2001;  26 1511-1515
• 20 Group EPOS . Incidence of vertebral fractures in Europe: results from the European prospective osteoporosis study (EPOS).  J Bone Miner Res. 2002;  17 716-724
• 21 Harris S T, Watts N B, Genant H K et al. Effects of risedronate treatment on vertebral and nonvertebral fractures in women with postmenopausal osteoporosis: a randomized controlled trial. Vertebral Efficacy With Risedronate Therapy (VERT) Study Group.  JAMA. 1999;  282 1344-1352
• 22 Harrop J S, Prpa B, Reinhardt M K et al. Primary and secondary osteoporosis' incidence of subsequent vertebral compression fractures after kyphoplasty.  Spine (Phila Pa 1976). 2004;  29 2120-2125
• 23 Heini P F, Orler R. Kyphoplasty for treatment of osteoporotic vertebral fractures.  Eur Spine J. 2004;  13 184-192
• 24 Huang M H, Barrett-Connor E, Greendale G A et al. Hyperkyphotic posture and risk of future osteoporotic fractures: the Rancho Bernardo study.  J Bone Miner Res. 2006;  21 419-423
• 25 Hulme P A, Krebs J, Ferguson S J et al. Vertebroplasty and kyphoplasty: a systematic review of 69 clinical studies.  Spine (Phila Pa 1976). 2006;  31 1983-2001
• 26 Johnell O, Oden A, Caulin F et al. Acute and long-term increase in fracture risk after hospitalization for vertebral fracture.  Osteoporos Int. 2001;  12 207-214
• 27 Kallmes D F, Comstock B A, Heagerty P J et al. A randomized trial of vertebroplasty for osteoporotic spinal fractures.  N Engl J Med. 2009;  361 569-579
• 28 Kanis J A, Johnell O, De Laet C et al. A meta-analysis of previous fracture and subsequent fracture risk.  Bone. 2004;  35 375-382
• 29 Klotzbuecher C M, Ross P D, Landsman P B et al. Patients with prior fractures have an increased risk of future fractures: a summary of the literature and statistical synthesis.  J Bone Miner Res. 2000;  15 721-739
• 30 Komp M, Ruetten S, Godolias G. Minimal-invasive Therapie der funktionell instabilen osteoporotischen Wirbelkörperfraktur mittels Kyphoplastie: Prospektive Vergleichsstudie von 19 operierten und 17 konservativ behandelten Patienten.  J Miner Stoffwechs. 2004;  11 (Suppl. 1) 13-16
• 31 Li J, Ahmad T, Spetea M et al. Bone reinnervation after fracture: a study in the rat.  J Bone Miner Res. 2001;  16 1505-1510
• 32 Liberman U A, Weiss S R, Broll J et al. Effect of oral alendronate on bone mineral density and the incidence of fractures in postmenopausal osteoporosis. The Alendronate Phase III Osteoporosis Treatment Study Group.  N Engl J Med. 1995;  333 1437-1443
• 33 Lieberman I H, Dudeney S, Reinhardt M K et al. Initial outcome and efficacy of “kyphoplasty” in the treatment of painful osteoporotic vertebral compression fractures.  Spine (Phila Pa 1976). 2001;  26 1631-1638
• 34 Lindsay R, Silverman S L, Cooper C et al. Risk of new vertebral fracture in the year following a fracture.  JAMA. 2001;  285 320-323
• 35 Mach D B, Rogers S D, Sabino M C et al. Origins of skeletal pain: sensory and sympathetic innervation of the mouse femur.  Neuroscience. 2002;  113 155-166
• 36 Meunier P J, Roux C, Seeman E et al. The effects of strontium ranelate on the risk of vertebral fracture in women with postmenopausal osteoporosis.  N Engl J Med. 2004;  350 459-468
• 37 Mudano A S, Bian J, Cope J U et al. Vertebroplasty and kyphoplasty are associated with an increased risk of secondary vertebral compression fractures: a population-based cohort study.  Osteoporos Int. 2009;  20 819-826
• 38 Nussbaum D A, Gailloud P, Murphy K. A review of complications associated with vertebroplasty and kyphoplasty as reported to the Food and Drug Administration medical device related web site.  J Vasc Interv Radiol. 2004;  15 1185-1192
• 39 Oleksik A, Lips P, Dawson A et al. Health-related quality of life in postmenopausal women with low BMD with or without prevalent vertebral fractures.  J Bone Miner Res. 2000;  15 1384-1392
• 40 Padovani B, Kasriel O, Brunner P et al. Pulmonary embolism caused by acrylic cement: a rare complication of percutaneous vertebroplasty.  AJNR Am J Neuroradiol. 1999;  20 375-377
• 41 Ronge R. Komplikationen nach Vertebroplastie und Kyphoplastie: Zementembolie am typischen Röntgenbild erkennbar?.  Fortschr Röntgenstr. 2005;  177 934
• 42 Ross P D, Genant H K, Davis J W et al. Predicting vertebral fracture incidence from prevalent fractures and bone density among non-black, osteoporotic women.  Osteoporos Int. 1993;  3 120-126
• 43 Rousing R, Hansen K L, Andersen M O et al. Twelve-months follow-up in forty-nine patients with acute/semiacute osteoporotic vertebral fractures treated conservatively or with percutaneous vertebroplasty: a clinical randomized study.  Spine (Phila Pa 1976). 2010;  35 478-482
• 44 Seibel M. Evaluation des osteoporotischen Frakturrisikos.  Dtsch Ärztebl. 2001;  98A 1681-1689
• 45 Serre C M, Farlay D, Delmas P D et al. Evidence for a dense and intimate innervation of the bone tissue, including glutamate-containing fibers.  Bone. 1999;  25 623-629
• 46 Silverman S L, Minshall M E, Shen W et al. The relationship of health-related quality of life to prevalent and incident vertebral fractures in postmenopausal women with osteoporosis: results from the Multiple Outcomes of Raloxifene Evaluation Study.  Arthritis Rheum. 2001;  44 2611-2619
• 47 Sornay-Rendu E, Munoz F, Garnero P et al. Identification of osteopenic women at high risk of fracture: the OFELY study.  J Bone Miner Res. 2005;  20 1813-1819
• 48 Strassberger C, Unger L, Weber A T et al. Bonnaire FA Management of osteoporosis-related bone fractures: an integrated concept of care.  Arch Orthop Trauma Surg. 2010;  130 103-109
• 49 Taylor R S, Fritzell P, Taylor R J. Balloon kyphoplasty in the management of vertebral compression fractures: an updated systematic review and meta-analysis.  Eur Spine J. 2007;  16 1085-1100
• 50 van der Klift M, de Laet C E, McCloskey E V et al. Risk factors for incident vertebral fractures in men and women: the Rotterdam Study.  J Bone Miner Res. 2004;  19 1172-1180
• 51 van Helden S, Cals J, Kessels F et al. Risk of new clinical fractures within 2 years following a fracture.  Osteoporos Int. 2006;  17 348-354
• 52 Walker-Bone K, Dennison E, Cooper C. Epidemiology of osteoporosis.  Rheum Dis Clin North Am. 2001;  27 1-18
• 53 Wardlaw D, Cummings S R, Van Meirhaeghe J et al. Efficacy and safety of balloon kyphoplasty compared with non-surgical care for vertebral compression fracture (FREE): a randomised controlled trial.  Lancet. 2009;  373 1016-1024
• 54 Wilson D R, Myers E R, Mathis J M et al. Effect of augmentation on the mechanics of vertebral wedge fractures.  Spine (Phila Pa 1976). 2000;  25 158-165